IGC Pharma, Inc.
IGC
$0.29
$0.000.32%
AMEX
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.94M | -2.40M | -1.82M | -1.60M | -1.20M |
| Total Depreciation and Amortization | 56.00K | 58.00K | 119.00K | 141.00K | 154.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.00M | 1.03M | -325.00K | 428.00K | 609.00K |
| Change in Net Operating Assets | 529.00K | 92.00K | -63.00K | -377.00K | -296.00K |
| Cash from Operations | -1.35M | -1.22M | -2.09M | -1.41M | -730.00K |
| Capital Expenditure | -5.00K | -1.00K | -29.00K | -8.00K | -18.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -23.00K | 702.00K | 24.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -249.00K | -169.00K | -322.00K | -114.00K | -148.00K |
| Cash from Investing | -254.00K | -170.00K | -374.00K | 580.00K | -142.00K |
| Total Debt Issued | 691.00K | 623.00K | -- | -- | -- |
| Total Debt Repaid | -- | -- | -1.00K | -1.00K | 0.00 |
| Issuance of Common Stock | 1.04M | 87.00K | 3.11M | 852.00K | 805.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.73M | 710.00K | 3.11M | 851.00K | 805.00K |
| Foreign Exchange rate Adjustments | -2.00K | -10.00K | 5.00K | 25.00K | 2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.00K | -693.00K | 651.00K | 49.00K | -65.00K |